Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature

Several cyclin‐dependent kinase 4/6 (CDK4/6) inhibitors are indicated in the treatment of metastatic hormone receptor‐positive (HR)/ human epidermal growth factor receptor 2 (HER2) negative breast cancer which includes palbociclib, ribociclib and abemaciclib. Pelvic radiation therapy (RT) is often i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dasgupta, Archya, Sahgal, Arjun, Warner, Ellen, Czarnota, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890927/
https://www.ncbi.nlm.nih.gov/pubmed/32985794
http://dx.doi.org/10.1002/jmrs.435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890927/
https://www.ncbi.nlm.nih.gov/pubmed/32985794
http://dx.doi.org/10.1002/jmrs.435

Ejemplares similares